Eyenovia, Inc. EYEN
7.56 0.00 (+0.00%)
Oct 20, 2025, 12:58 PM EDT
7.28 Day range 7.82
52-week range unavailable
- YTD
- -35.27%
- 1 year
- -87.28%
Analyst view
Price target (mean) 3.50 -53.7% downside
Now 7.56
- Target (low)
- 2.00
- Target (mean)
- 3.50
- Target (high)
- 5.00
Ratings (0m) 3 0 buy · 3 hold · 0 sell
- Strong buy0
- Buy0
- Hold3
- Sell0
- Strong sell0
Recommendation trend
- This month 3
- 1 month ago 4
- 2 months ago 4
- 3 months ago 4
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.09 | -0.10 – -0.08 | -0.16 | +43.8% | 848.50K | +32660.6% | 2 |
| Next quarter | -0.12 | -0.12 – -0.12 | -0.1914 | +37.3% | 400.00K | +7916.0% | 1 |
| Current year | -0.595 | -0.62 – -0.57 | -0.66 | +9.9% | 863.00K | +22670.5% | 2 |
| Next year | -0.415 | -0.46 – -0.37 | -0.595 | +30.3% | 4.37M | +406.3% | 2 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 18, 2024 | Ladenburg Thalmann | Downgrade | Buy | Neutral |
| Nov 18, 2024 | HC Wainwright & Co. | Downgrade | Buy | Neutral |
| Nov 15, 2024 | William Blair | Downgrade | Outperform | Market Perform |
| Nov 15, 2024 | Brookline Capital | Downgrade | Buy | Hold |
| Nov 13, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 13, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jul 24, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 16, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Mar 19, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Mar 6, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Nov 14, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Nov 1, 2023 | William Blair | Initiated | — | Outperform |
| Oct 17, 2023 | Brookline Capital | Initiated | — | Buy |
| Aug 18, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 11, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 12, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Apr 19, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |
| Apr 3, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |
| Oct 5, 2022 | HC Wainwright & Co. | Initiated | — | Buy |
| Apr 1, 2021 | HC Wainwright & Co. | Maintained | — | Buy |
| Oct 23, 2020 | HC Wainwright & Co. | Maintained | — | Buy |
| Oct 14, 2020 | Roth Capital | Maintained | — | Buy |
| Aug 13, 2020 | HC Wainwright & Co. | Maintained | — | Buy |
| Mar 26, 2020 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Feb 3, 2020 | Oppenheimer | Downgrade | Outperform | Perform |
| Apr 25, 2019 | Oppenheimer | Initiated | — | Outperform |
| Oct 9, 2018 | HC Wainwright & Co. | Initiated | — | Buy |
| Feb 20, 2018 | Roth Capital | Initiated | — | Buy |
